NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma 
progression via JAK2/STAT5 inhibition

Vesting, Anna Juliane; Jais, Alexander; Klemm, Paul; Steuernagel, Lukas; Wienand, Peter; Fog-Tonnesen, Morten; Hvid, Henning; Schumacher, A. L.; Kukat, C.; Nolte, H.; Georgomanolis, Theodoros; Altmüller, Janine; Pasparakis, Manolis; Schmidt, Andreas; Krüger, Marcus; Supprian, Marc Schmidt; Waisman, Ari; Straub, Beate Katharina; Raschzok, Nathanael; Bernier, Michel; Birkenfeld, Andreas L.; Hövelmeyer, Nadine; Brüning, Jens C.; Wunderlich, F. Thomas

doi:10.1016/j.molmet.2022.101626

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition

MPS-Authors

/persons/resource/persons278042

Schumacher, A. L.
FACS & Imaging, Core Facilities, Max Planck Institute for Biology of Ageing, Max Planck Society;

/persons/resource/persons129360

Kukat, C.
FACS & Imaging, Core Facilities, Max Planck Institute for Biology of Ageing, Max Planck Society;

/persons/resource/persons276056

Nolte, H.
Department Langer - Mitochondrial Proteostasis, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Vesting, A. J., Jais, A., Klemm, P., Steuernagel, L., Wienand, P., Fog-Tonnesen, M., et al. (2022). NIK/MAP3K14 in hepatocytes orchestrates NASH to hepatocellular carcinoma progression via JAK2/STAT5 inhibition. Molecular Metabolism, 66: 101626, pp. 101626. doi:10.1016/j.molmet.2022.101626.

Cite as: https://hdl.handle.net/21.11116/0000-000C-2888-E

Abstract

There is no abstract available